BMY vs OLPX · P/E 17, rev $24.46B vs P/E 70, rev $423.0M
Bristol-Myers Squibb Company (BMY) versus Olaplex Holdings Inc (OLPX) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Olaplex Holdings Inc (OLPX) is a specialty retail company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported OLPX revenue for 2025-12-31 was $423.0M. Net income was -$9.3M. Revenue was up 0.1% from 2024-12-31 to 2025-12-31. OLPX currently screens at market cap $932.3M and trailing P/E 70.0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. OLPX currently screens at market cap $932.3M and trailing P/E 70.0.
Not investment advice. Open the BMY and OLPX stock pages for the full models.
Not investment advice.